Saturday 17 October 2026
Export AHI’s income statement to Excel — free account
Advanced Human Imaging Limited Sponsored ADR
AHI Technology Software Application
Advanced Human Imaging Limited Sponsored ADR’s revenue for fiscal 2023 (year ended June 2023) was $1.9 million, up 484.3% from fiscal 2022. Revenue growth for three consecutive years, operating cash flow growth for three.
1.50
0.00
0.00%
Follow AHI
| Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 4 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
112.47 | 66.00 | 519.26 | 519.26 | 519.26 | 519.26 | — |
Altman Z-Score |
(13.29) | (9.12) | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(38.80) | (25.06) | (42.37) | (46.48) | (60.95) | (131.05) | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
(1.44) | (8.17) | (11.03) | — | — | — | — |
P/Operating CF |
(52.13) | (31.58) | (230.31) | (230.31) | (230.31) | (230.31) | — |
P/B ratio |
47.60 | 6.34 | 145.13 | 145.13 | 145.13 | 145.13 | — |
Price to Tangible BV |
0.00 | 7.16 | 376.72 | 376.72 | 376.72 | 376.72 | — |
EV/Sales |
112.04 | 60.12 | 519.37 | 519.37 | 519.37 | 519.37 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(3.70) | (2.44) | (32.09) | (32.09) | (32.09) | (32.09) | — |
EV/FCF |
(3.66) | (2.41) | (32.09) | (32.09) | (32.09) | (32.09) | — |
Quick Ratio |
0.40 | 2.96 | 0.71 | 0.45 | 0.29 | 0.37 | 3.01 |
Current Ratio |
0.54 | 3.40 | 1.18 | 0.60 | 0.29 | 0.45 | 3.17 |
Net Debt/EBITDA |
0.03 | 0.24 | 0.00 | (0.12) | (0.17) | (0.02) | 0.39 |
Debt/Assets |
19.52% | 10.41% | 41.12% | 44.86% | 56.90% | 23.91% | 0.00% |
Debt/Equity |
0.86 | 0.13 | 1.13 | 2.87 | 2.73 | 0.69 | 0.00 |
Asset Turnover |
0.27 | 0.05 | 0.29 | 0.28 | 0.00 | 1.60 | 0.00 |
Operating CF/Net income |
0.57 | 0.49 | 0.29 | 0.50 | 0.75 | 0.09 | 0.83 |
Capex/Depreciation |
(0.18) | (0.24) | (0.07) | (0.25) | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(26.38) | (127.88) | (58.38) | (41.22) | (82.61) | (2,443.89) | (117.87) |
| (228.08%) | (355.91%) | (1,152.26%) | (1,275.35%) | (677.61%) | (850.28%) | (138.90%) | |
| (125.76%) | (221.40%) | (335.76%) | (225.12%) | (183.02%) | (1,384.20%) | (90.94%) | |
ROIC |
(474.08%) | (358.47%) | (449.56%) | (318.73%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
488.89% | (400.91%) | (2,097.72%) | 736.72% | 306.41% | 3,305.51% | (245.36%) |
Average Days of Receivables |
40.80 | 42.12 | 73.86 | 160.89 | 2,015.43 | 30.69 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.94% | — |
Selling, General and Administrative Expense of Revenue |
357.60% | 4,485.41% | 1,083.47% | 987.16% | 118,504.35% | 1,015.62% | 0.00% |
Intangible Assets out of Total Assets |
0.48 | 0.09 | 0.22 | 0.46 | 0.55 | 0.78 | 0.00 |
Share Based Compensation of Revenue |
3.76% | 1,681.74% | 606.84% | 310.82% | 0.00% | 0.00% | — |
Graham Net Nets |
(0.04) | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(3.84%) | (8.54%) | (0.74%) | (0.74%) | (0.74%) | (0.74%) | — |
Free Cash Flow Yield |
(27.21%) | (37.81%) | (3.12%) | (3.12%) | (3.12%) | (3.12%) | — |
Revenue per Share |
0.28 | 0.06 | 0.27 | 0.18 | 0.00 | 0.10 | 0.00 |
Operating CF per Share |
(0.75) | (1.30) | (0.92) | (0.72) | (0.64) | (0.08) | (0.11) |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.02) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.76) | (1.32) | (0.92) | (0.74) | (0.64) | (0.08) | (0.11) |
Cash per Share |
0.21 | 0.80 | 0.48 | 0.17 | 0.11 | 0.01 | 0.07 |
Shareholders Equity per Share |
0.21 | 1.13 | 0.44 | 0.12 | 0.11 | 0.04 | 0.14 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.21 | 1.13 | 0.44 | 0.12 | 0.11 | 0.04 | 0.14 |
Free Cash Flow |
(5.00) | (7.22) | (4.13) | (2.76) | (2.28) | (0.95) | (1.40) |
Working Capital |
(1.87) | 3.56 | 0.61 | (0.81) | (1.03) | (0.34) | 0.66 |
Capital Expenditures |
(0.05) | (0.06) | (0.02) | (0.06) | (0.06) | (0.15) | (0.54) |
Net Current Asset Value |
(2.44) | 3.52 | 0.56 | (1.27) | (1.03) | (0.70) | 0.66 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.02 | 0.19 | 0.02 | 0.09 | 0.00 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||
Depreciation/Fixed assets |
2.43 | 3.84 | 5.96 | 3.14 | 3.56 | 4.67 | 0.41 |
Cash ROIC |
(126.64%) | (63.44%) | (64.67%) | (114.26%) | (124.39%) | (95.37%) | (49.82%) |
Accounts Receivable Turnover |
15.20 | 2.29 | 4.47 | 4.28 | 0.05 | 19.13 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.88 | 0.15 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 18.86 | 1.46 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 254.30 | 1,730.47 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 9.40 | 378.13 |
Average Receivables |
0.12 | 0.14 | 0.27 | 0.16 | 0.06 | 0.06 | 0.06 |
Average Payables |
1.35 | 0.46 | 0.67 | 0.43 | 0.08 | 0.07 | 0.07 |
Average Inventory |
— | — | — | 0.00 | 0.00 | 0.01 | 0.01 |
Average Assets |
6.87 | 6.58 | 4.19 | 2.40 | 1.66 | 0.74 | 1.85 |
Average Common Equity |
3.79 | 4.09 | 1.22 | 0.42 | 0.45 | 1.21 | 1.21 |
Columns are period end dates